4//SEC Filing
Young David 4
Accession 0000897069-25-001545
CIK 0001533743other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:25 PM ET
Size
7.5 KB
Accession
0000897069-25-001545
Insider Transaction Report
Form 4
Young David
DirectorPres. Research & Development
Transactions
- Award
Stock Options (Right to Buy)
2025-10-01+333,000→ 333,000 totalExercise: $0.20→ Common Stock (333,000 underlying) - Award
Restricted Stock Units
2025-10-01+111,000→ 111,000 totalExercise: $0.00→ Common Stock (111,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.
- [F2]Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001378166
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:25 PM ET
- Size
- 7.5 KB